Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena M Hartmann

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|April 10, 2008
Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?Elena M Hartmann, Andreas Rosenwald
Leukemia & Lymphoma|April 15, 2010
Gene expression signatures of adult T-cell leukemia: is treatment response prediction on the horizon?Elena M Hartmann, Andreas Rosenwald
Future Oncology (London, England)|February 27, 2009
Molecular outcome prediction in mantle cell lymphomaElena M Hartmann, German Ott, Andreas Rosenwald
Hematology/Oncology Clinics of North America|October 29, 2008
Molecular biology and genetics of lymphomasElena M Hartmann, German Ott, Andreas Rosenwald
Leukemia & Lymphoma|October 13, 2015
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltratesElena M Hartmann, Martina Rudelius, Jan A Burger, et al.
Advances in Experimental Medicine and Biology|February 3, 2007
Gene expression profiling in malignant lymphomasSarah E Henrickson, Elena M Hartmann, German Ott, et al.
Annals of Hematology|July 20, 2020
A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency typeMathias T Rosenfeldt, Elena M Hartmann, Corinna Leng, et al.
Seminars in Cancer Biology|September 28, 2011
The complex landscape of genetic alterations in mantle cell lymphomaCristina Royo, Itziar Salaverria, Elena M Hartmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 5, 2012
Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expressionElena M Hartmann, Sílvia Beà, Alba Navarro, et al.
Plos One|January 4, 2013
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosisThomas F Benkert, Lena Dietz, Elena M Hartmann, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|April 10, 2008
Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?Elena M Hartmann, Andreas Rosenwald
Leukemia & Lymphoma|April 15, 2010
Gene expression signatures of adult T-cell leukemia: is treatment response prediction on the horizon?Elena M Hartmann, Andreas Rosenwald
Future Oncology (London, England)|February 27, 2009
Molecular outcome prediction in mantle cell lymphomaElena M Hartmann, German Ott, Andreas Rosenwald
Hematology/Oncology Clinics of North America|October 29, 2008
Molecular biology and genetics of lymphomasElena M Hartmann, German Ott, Andreas Rosenwald
Leukemia & Lymphoma|October 13, 2015
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltratesElena M Hartmann, Martina Rudelius, Jan A Burger, et al.
Advances in Experimental Medicine and Biology|February 3, 2007
Gene expression profiling in malignant lymphomasSarah E Henrickson, Elena M Hartmann, German Ott, et al.
Annals of Hematology|July 20, 2020
A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency typeMathias T Rosenfeldt, Elena M Hartmann, Corinna Leng, et al.
Seminars in Cancer Biology|September 28, 2011
The complex landscape of genetic alterations in mantle cell lymphomaCristina Royo, Itziar Salaverria, Elena M Hartmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 5, 2012
Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expressionElena M Hartmann, Sílvia Beà, Alba Navarro, et al.
Plos One|January 4, 2013
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosisThomas F Benkert, Lena Dietz, Elena M Hartmann, et al.
Pageof 2